GSK1795091
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK1795091, covering 2019-06-10 to 2021-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors [Phase 1]